Orthofix Medical Inc.

OFIX | $13.225 1.11% 1.1% 220K

(0.0% 1d) (-3.5% 1m) (-31.5% 1y) (0.0% 2d) (0.0% 3d) (0.6% 7d) (-100.0% volume)
Earnings Calendar: 2024-03-05
Market Cap: $ 494,702,867
http://www.orthofix.com
Sec Filling | Patents | 1055 employees

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

bone

add to watch list Paper trade email alert is off

Press-releases

Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
OFIX | $13.225 1.11% 1.1% 220K

Health Technology

| 0.0% | O: 2.45% H: 0.0% C: 0.0%
first conference for

Orthofix Names Andres Cedron as New Chief Legal Officer
Published: 2024-04-16 (Crawled : 13:00) - biospace.com/
SYK | $334.91 2.21% -4.72% 1.4M

Health Technology

| -3.38% | O: 0.59% H: 0.09% C: -1.02%
OFIX | $13.225 1.11% 1.1% 220K

Health Technology

| -0.08% | O: -0.31% H: 1.99% C: 1.0%

Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
Published: 2024-03-18 (Crawled : 12:30) - biospace.com/
OFIX | $13.225 1.11% 1.1% 220K

Health Technology

| -4.8% | O: 0.44% H: 0.65% C: -3.55%
business

Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024
Published: 2024-02-21 (Crawled : 18:00) - biospace.com/
OFIX | $13.225 1.11% 1.1% 220K

Health Technology

| -4.94% | O: -0.87% H: 0.22% C: -0.15%
conference year

Orthofix Announces Commercial Partnership with MRIguidance
Published: 2024-01-18 (Crawled : 12:30) - biospace.com/
OFIX | $13.225 1.11% 1.1% 220K

Health Technology

| -1.65% | O: 0.15% H: 0.45% C: -0.53%
partnership commercial

Julie Andrews Begins as New Chief Financial Officer at Orthofix
Published: 2024-01-16 (Crawled : 12:30) - biospace.com/
OFIX | $13.225 1.11% 1.1% 220K

Health Technology

| -4.18% | O: -1.76% H: 1.64% C: 1.42%
financial

Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
Published: 2024-01-09 (Crawled : 20:00) - biospace.com/
OFIX | $13.225 1.11% 1.1% 220K

Health Technology

| -1.58% | O: 5.34% H: 5.86% C: 4.21%
sales medical results

Ankle Fusion Nail Market Size to Surpass US$ 1,145.2 Million by 2030 - CoherentMI
Published: 2023-12-19 (Crawled : 18:00) - prnewswire.com
SYK | $334.91 2.21% -4.72% 1.4M

Health Technology

| 12.23% | O: 0.09% H: 0.54% C: -1.35%
OFIX | $13.225 1.11% 1.1% 220K

Health Technology

| -2.39% | O: 0.22% H: 4.69% C: -0.22%
market

Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc
Published: 2023-11-29 (Crawled : 15:30) - biospace.com/
OFIX | $13.225 1.11% 1.1% 220K

Health Technology

| 16.47% | O: 0.8% H: 2.3% C: -0.53%
spine publication

Orthofix Names Massimo Calafiore as President and Chief Executive Officer
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
OFIX | $13.225 1.11% 1.1% 220K

Health Technology

| 12.27% | O: 0.0% H: 2.66% C: -3.61%

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0000950170-24-043032	4	2024-04-09	2024-04-08	Sell	F	47486	112803
0000950170-24-041107	4	2024-04-03	2024-04-01	Sell	F	70	40772
0000950170-24-029983	4	2024-03-12	2024-01-31	Buy	A	8350	23350
0000950170-24-011265	4	2024-02-05	2024-02-01	Sell	F	2015	236983